“Thomas went above and beyond with supporting my journey in getting the career of my dreams. I highly recommend him if you’re in the market for a new opportunity. Thanks again, Thomas!”

Director of Business Development, Porsolt

Porsolt is a long-established preclinical CRO, having started operations in 1984 under the name ITEM-Labo. Porsolt has obtained an international reputation for expertise in physiopathological models, customised procedures and tailored solutions for discovering treatments of psychiatric and neurological disorders, acute and chronic pain, inflammation, cardiac and vascular diseases, and metabolic and eating disorders.

Porsolt also offers services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in full compliance with GLP. Porsolt’s safety program includes full assessment of arrhythmogenic risk and abuse/dependence liability. Porsolt is headquartered in France with research facilities in Laval.

Company website – https://www.porsolt.com/ 

​To find out more about Porsolt, contact Thomas White on +44 (0)20 3854 7700 or thomas.white@mantellassociates.com.